Discover 4,573 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,573
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: The Bronx NY, New York NY, East Brunswick NJ,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT06095089
Phase 1, Recruiting
Belatacept in De Novo Heart Transplantation
for
Heart Transplantation
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 70+
Code: NCT04477629
Phase 2, Recruiting
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
for
T Cell Non-Hodgkin Lymphoma
Location: New York NY, Philadelphia PA
Sponsor: Vittoria Biotherapeutics
Sex: All
Age: 18+
Code: NCT06420089
Phase 1, Recruiting
Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes
Location: Boston MA, New Haven CT, Rosedale NY, New York NY,
Sponsor: Eidos Therapeutics, a BridgeBio company
Sex: All
Age: 18 - 70+
Code: NCT06563895
Phase 3, Recruiting
Everolimus Post Orthotopic Liver Transplant
for
Orthotopic Liver Transplant
Location: New York NY
Sponsor: Tomoaki Kato
Sex: All
Age: 18+
Code: NCT01998789
Phase 2, Recruiting
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
for
Metastatic Breast Cancer, Triple Negative Breast Cancer,
Location: Durham NC, Buffalo NY, Atlanta GA, Lexington KY,
Sponsor: Kathy Miller
Sex: All
Age: 18+
Code: NCT05846789
Phase 2, Recruiting
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
for
Carcinoma, Hepatocellular, Liver Cell Carcinoma
Location: The Bronx NY, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05366829
Phase 2, Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Halifax, Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
Community-based Implementation of Online EmReg
for
Traumatic Brain Injury, Emotion Regulation
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT05933629
Recruiting
Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
for
Surgical Wound, Hypo-pigmented Skin
Location: New York NY
Sponsor: Momelan Technologies
Sex: All
Age: 18+
Code: NCT01590329
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: Bloomfield CT, Laurelton NY, Maspeth NY, Jersey City NJ,
Sponsor: Maze Therapeutics
Sex: All
Age: 18 - 68
Code: NCT06830629
Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Boston MA, Hawthorne NY, Staten Island NY,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Boston MA, The Bronx NY, Hackensack NJ, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Location: Ney York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT03567889
Phase 3, Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.